Hydrocephalus Shunts Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 510.21 Million |
| Market Size (2029) | USD 595.83 Million |
| CAGR (2024 - 2029) | 3.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Hydrocephalus Shunts Market Analysis
The Hydrocephalus Shunts Market size is estimated at USD 510.21 million in 2024, and is expected to reach USD 595.83 million by 2029, growing at a CAGR of 3.20% during the forecast period (2024-2029).
Various factors contribute to the market's growth, such as the rising prevalence of brain and neurological disorders, the increasing geriatric population, and the rising adoption of advanced programmable valves in the medical field, particularly in neurosurgery for conditions such as hydrocephalus to improve clinical results and ensure patient safety.
An increase in patients suffering from neurological disorders is expected to be the critical factor contributing to the market's growth. Severe head injuries and meningitis can lead to hydrocephalus by causing bleeding in or around the brain, especially when the infection affects the ventricles or the flow of cerebrospinal fluid (CSF). For instance, according to the Meningitis Weekly Bulletin - West Africa 2023 report, 3,551 CSF were tested for meningitis in week 18 of 2023 in Africa. The high burden of meningitis can lead to an increase in the adoption of hydrocephalus shunts and drive the market's growth. For instance, as per the above-mentioned source, around 10,326 suspected cases of meningitis were reported by 22 countries in week 18 of 2023. Thus, the high number of cases of meningitis-related hydrocephalus is anticipated to boost the adoption of hydrocephalus shunts for its treatment and fuel the market's growth.
Furthermore, strategies of the market players, such as product launches and significant investments in developing innovative hydrocephalus shunts, are expected to propel the market's growth. For instance, in July 2023, Anuncia Medical Inc. launched the next-generation device ReFlow Mini Flusher device for the treatment of patients with hydrocephalus that requires shunting and improves the lives of patients across the United States. Additionally, in February 2023, Rhaeos raised USD 10.5 million in Series A Funding to launch a novel hydrocephalus shunt monitor and accelerate pipeline product development in the United States. These studies help expand the existing shunt portfolio with new devices expected to propel the market over the coming years.
Therefore, owing to factors such as the high burden of neurological disorders, rising research studies for developing advanced shunts, product approvals, and launches by market players, the studied market is anticipated to witness growth. However, shunt malfunction and infection are expected to restrain the market's growth.
Hydrocephalus Shunts Market Trends
Hydrocephalus Catheters are Expected to Hold a Significant Share in the Market During the Forecast Period
Hydrocephalus catheters are essential in managing hydrocephalus, and specific patient populations are at greater risk of developing shunt infections. These catheters are flexible tubes designed to carry excess cerebrospinal fluid (CSF) from the brain to another area of the body, allowing for absorption and alleviating pressure on the brain.
Advancements in catheters are expected to increase the adoption and propel the market's growth. For instance, in July 2023, the neurosurgeons at the Medical University of South California utilized the device ReFlow due to its ability to reverse the fluid flow within the catheter, which significantly decreased the number of follow-up surgeries needed for patients with hydrocephalus. Thus, increasing the use of such devices is anticipated to drive the segment's growth.
Furthermore, the research and developments by market players to expand the catheter solution are also expected to propel the segment’s growth. For instance, in May 2023, Anuncia Medical Inc. reported positive clinical trial outcome data using the ReFlow Ventricular System In-Line with Hydrocephalus Shunts. The ReFlow Ventricular System comprises an in-line flusher and a proprietary ventricular catheter. The rising research initiatives are expected to expand the availability of advanced hydrocephalus catheters in the upcoming years, accelerating the segment's growth.
Therefore, owing to the aforementioned factors, such as technological advancements and expansions by market players, the segment is expected to register a significant growth rate during the forecast period.
North America is Expected to Hold a Significant Share in the Market During the Forecast Period
North America is expected to hold a significant share of the market due to factors such as the high burden of hydrocephalus, increased research and development (R&D) spending, product launches, approvals, and the high concentration of market players in the region.
The increasing prevalence of brain disorders is leading to a high demand for advanced shunts for treating hydrocephalus. For instance, the data published by the National Institute of Neurological Disorders and Stroke in July 2024 mentioned that one to two out of every 1,000 babies are born with hydrocephalus in the United States. Thus, the significant burden of hydrocephalus in the country is expected to increase the demand for hydrocephalus shunts, thereby boosting the market's growth during the forecast period.
Furthermore, neurosurgeons prefer the latest technology shunts, and the increasing adoption of technologically advanced shunts is expected to boost the market during the forecast period. For instance, in November 2023, surgeons at Intermountain Primary Children's Hospital in Utah, United States, successfully implanted a new brain shunt accessory with an Anuncia Medical implant called the ReFlow Mini Flusher designed for young patients suffering from hydrocephalus. The device has been demonstrated to remain in position more effectively and prevent clogging due to its design. Thus, such advanced hydrocephalus shunts are employed by surgeons and are expected to drive the market's growth in the region.
Moreover, in September 2023, researchers at Wayne State University specializing in hydrocephalus research were awarded a new round of National Institutes of Health (NIH) funding totaling USD 2.6 million to further advance their efforts in enhancing shunt design. The rising grants for developing innovative hydrocephalus shunts are expected to propel the market's growth in the region during the forecast period.
Therefore, owing to the above-mentioned factors, such as the high burden of hydrocephalus, rising R&D spending, and product approvals and launches by market players, the growth of the studied market is anticipated in North America.
Hydrocephalus Shunts Industry Overview
The hydrocephalus shunts market is consolidated in nature due to the presence of a few market players. Some of the major players are B. Braun SE (Christoph Miethke), Medtronic PLC, Spiegelberg GmbH & Co. KG, Tokibo Co. Ltd (Sophysa), Natus Medical Incorporated, and Integra LifeSciences Corporation.
Hydrocephalus Shunts Market Leaders
-
Medtronic
-
Spiegelberg GmbH & Co. KG
-
Tokibo Co., Ltd. (Sophysa)
-
Natus Medical Incorporated
-
B. Braun SE (Christoph Miethke)
*Disclaimer: Major Players sorted in no particular order
Hydrocephalus Shunts Market News
- July 2024: The Department of Defense (DOD) awarded a USD 5.6 million grant to Senseer Health Inc. to advance innovative technology for monitoring hydrocephalus shunts. The creation of the MultiSense microsensor by Senseer Health Inc. provides optimism for patients and their families, as it promises to reduce complications and enhance overall quality of life.
- May 2024: CereVasc Inc. obtained approval from the United States Food and Drug Administration (US FDA) to begin its innovative STRIDE pivotal study, which will evaluate the safety and effectiveness of its new eShunt System for treating patients with Normal Pressure Hydrocephalus, compared to the existing standard of care, the ventriculo-peritoneal (VP) shunt.
Hydrocephalus Shunts Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Prevalence of Brain and Neurological Disorder
4.2.2 Increase in Geriatric Population
4.2.3 Increasing Adoption of Advanced Programmable Valves
4.3 Market Restraints
4.3.1 Shunt Malfunction and Shunt Infection
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Product Type
5.1.1 Hydrocephalus Valves
5.1.1.1 Adjustable Pressure Valves
5.1.1.2 Fix Pressure Valves
5.1.2 Hydrocephalus Catheters
5.1.3 Shunt Systems
5.2 By Age Group
5.2.1 Pediatric
5.2.2 Adult
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Ambulatory Surgical Centers
5.3.3 Other End Users
5.4 By Geography
5.4.1 North America
5.4.2 Europe
5.4.3 Asia-Pacific
5.4.4 Rest of the World
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun SE (Christoph Miethke)
6.1.2 Medtronic PLC
6.1.3 Natus Medical Incorporated
6.1.4 Tokibo Co. Ltd (Sophysa)
6.1.5 Spiegelberg GmbH & Co. KG
6.1.6 Bıçakcılar
6.1.7 Integra LifeSciences Corporation
6.1.8 Kaneka Corporation (Kaneka Medix Corporation)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Hydrocephalus Shunts Industry Segmentation
As per the scope of the report, a hydrocephalus shunt is a medical device that helps treat a condition in the brain in which excessive accumulation of cerebrospinal fluid occurs, resulting in increased intracranial pressure within the skull. These devices relieve pressure on the brain caused by fluid accumulation.
The hydrocephalus shunts market is segmented by product type, age group, end user, and geography. By product type, the market is segmented into hydrocephalus valves and hydrocephalus catheters (shunt systems). By age group, the market is segmented into pediatric and adult. By end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. For each segment, the market size is provided in terms of value (USD).
| By Product Type | ||||
| ||||
| Hydrocephalus Catheters | ||||
| Shunt Systems |
| By Age Group | |
| Pediatric | |
| Adult |
| By End User | |
| Hospitals and Clinics | |
| Ambulatory Surgical Centers | |
| Other End Users |
| By Geography | |
| North America | |
| Europe | |
| Asia-Pacific | |
| Rest of the World |
Hydrocephalus Shunts Market Research Faqs
How big is the Hydrocephalus Shunts Market?
The Hydrocephalus Shunts Market size is expected to reach USD 510.21 million in 2024 and grow at a CAGR of 3.20% to reach USD 595.83 million by 2029.
What is the current Hydrocephalus Shunts Market size?
In 2024, the Hydrocephalus Shunts Market size is expected to reach USD 510.21 million.
Who are the key players in Hydrocephalus Shunts Market?
Medtronic, Spiegelberg GmbH & Co. KG, Tokibo Co., Ltd. (Sophysa), Natus Medical Incorporated and B. Braun SE (Christoph Miethke) are the major companies operating in the Hydrocephalus Shunts Market.
Which is the fastest growing region in Hydrocephalus Shunts Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Hydrocephalus Shunts Market?
In 2024, the North America accounts for the largest market share in Hydrocephalus Shunts Market.
What years does this Hydrocephalus Shunts Market cover, and what was the market size in 2023?
In 2023, the Hydrocephalus Shunts Market size was estimated at USD 493.88 million. The report covers the Hydrocephalus Shunts Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Hydrocephalus Shunts Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Hydrocephalus Shunts Industry Report
The report provides a comprehensive industry analysis of the Global Hydrocephalus Shunts market, focusing on key segments such as product type, age group, end user, and geography. The industry overview highlights the segmentation by Hydrocephalus Valves and Hydrocephalus Catheters, as well as the differentiation between pediatric and adult age groups. The market analysis includes insights into the end users, specifically hospitals and ambulatory surgical centers, and offers a detailed market forecast and market growth outlook.
The industry reports cover various geographical regions including North America, Europe, Asia-Pacific, Middle-East and Africa, and South America, providing a market review and market segmentation based on these areas. The market leaders and market trends are discussed, showcasing the market value and market size within the industry. Additionally, the report example and report pdf are available for a more in-depth understanding of the market data and market predictions.
This industry research includes a detailed market forecast that projects future market growth and provides an industry outlook based on current market statistics and market trends. The market overview and market segmentation offer valuable insights into the market leaders and the competitive landscape. The report also provides an analysis of the industry size and industry sales, highlighting the key drivers of market growth and the overall market value.
The industry information and industry research presented in the report are crucial for understanding the market dynamics and the factors influencing market growth. The market data and market predictions are supported by extensive research companies and industry statistics, ensuring the accuracy and reliability of the information provided. The report serves as a valuable resource for stakeholders looking to gain a comprehensive understanding of the Global Hydrocephalus Shunts market and its future prospects.
